ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
-0,01%
Bitcoin
63.134,28
0,39%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Cyclo Therapeutics Inc (CYTH)

  7. Cyclo Therapeutics Inc (CYTH) News

CYTH Cyclo Therapeutics Inc

1,51
0,04 (2,72%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Cyclo Therapeutics Inc CYTH NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,04 2,72% 1,51 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,50 1,48 1,55 1,51 1,47
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
18.3.202414:05BWCyclo Therapeutics Reports Full Year 2023 Financial Results..
14.3.202414:34BWCyclo Therapeutics Announces Issuance of U.S. Patent..
13.3.202422:04GLOBERafael Holdings Reports Second Quarter Fiscal 2024 Financial..
04.3.202422:33EDGAR2Form 8-K/A - Current report: [Amend]
15.2.202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202420:44EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
29.1.202415:15BWCyclo Therapeutics Announces Allowance of Patent Application..
22.1.202412:01EDGAR2Form 8-K - Current report
29.12.202303:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.12.202303:48EDGAR2Form 3 - Initial statement of beneficial ownership of..
28.12.202322:28EDGAR2Form 8-K - Current report
28.12.202302:25EDGAR2Form 8-K - Current report
27.12.202322:15BWCyclo Therapeutics, Inc. Completes Merger with Applied..
26.12.202322:15EDGAR2Form 8-K - Current report
18.12.202315:15BWCyclo Therapeutics Announces Positive Outcome from Type C..
18.12.202312:02EDGAR2Form 425 - Prospectuses and communications, business..
18.12.202312:01EDGAR2Form 8-K - Current report
14.12.202322:01GLOBERafael Holdings Reports First Quarter Fiscal 2024 Financial..
30.11.202322:30EDGAR2Form 425 - Prospectuses and communications, business..
30.11.202322:29EDGAR2Form 8-K - Current report
30.11.202315:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.11.202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.11.202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.11.202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.11.202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.11.202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.11.202315:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.11.202315:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21.11.202314:05BWCyclo Therapeutics to Present at the 20th Annual..
20.11.202314:50EDGAR2Form S-4/A - Registration of securities, business..
15.11.202314:05BWCyclo Therapeutics Reports Third Quarter 2023 Financial..
14.11.202320:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202322:45EDGAR2Form S-4 - Registration of securities, business combinations
31.10.202321:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.10.202321:01GLOBERafael Holdings Reports Fourth Quarter and Full Year Fiscal..
24.10.202322:43EDGAR2Form SC 13D/A - General statement of acquisition of..
23.10.202314:05BWCyclo Therapeutics Announces Early Exercise of Warrants by..
23.10.202312:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.10.202312:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.10.202312:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.10.202312:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.10.202312:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.10.202320:19EDGAR2Form 8-K - Current report
05.10.202314:05BWCyclo Therapeutics to Present at 8th Annual Dawson James..

Kürzlich von Ihnen besucht

NASDAQ
CYTH
Cyclo Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten